These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35536535)

  • 41. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
    Morimoto S; Ichihara A
    Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary aldosteronism: Treatment of the disease, and new therapeutic approaches.
    Funder J
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101368. PubMed ID: 31813785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
    Wachtel H; Fraker DL
    Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Primary aldosteronism: from diagnosis to therapy in clinical practice].
    Vetri M; Cassaniti L; Francese GM; Gulizia MM
    G Ital Cardiol (Rome); 2021 Apr; 22(4):319-326. PubMed ID: 33783452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update in primary aldosteronism.
    Stowasser M
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3623-30. PubMed ID: 19737921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension.
    Pelliccia F; Rosano G; Patti G; Volterrani M; Greco C; Gaudio C
    Int J Cardiol; 2015 Dec; 200():8-11. PubMed ID: 25466561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
    Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
    Amar L; Plouin PF; Steichen O
    Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
    Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
    J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism.
    Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Oki K; Kamemura K; Tanabe A; Naruse M;
    Hypertension; 2021 Feb; 77(2):537-545. PubMed ID: 33356395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary aldosteronism, diagnosis and treatment in Japan.
    Takeda Y; Karashima S; Yoneda T
    Rev Endocr Metab Disord; 2011 Mar; 12(1):21-5. PubMed ID: 21424323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence and blood pressure control in patients with primary aldosteronism.
    Nikrýnová Nguyen TMP; Štrauch B; Petrák O; Krátká Z; Holaj R; Kurcová I; Marešová V; Pilková A; Hartinger J; Waldauf P; Zelinka T; Widimský J
    Blood Press; 2022 Dec; 31(1):58-63. PubMed ID: 35438025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and management of primary aldosteronism: an updated review.
    Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
    Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Primay hyperaldosteronism--diagnostic and treatment].
    Potthoff SA; Beuschlein F; Vonend O
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary aldosteronism - treatment options.
    Young WF
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S102-8. PubMed ID: 12914736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary Aldosteronism and Pregnancy.
    Zelinka T; Petrák O; Rosa J; Holaj R; Štrauch B; Widimský J
    Kidney Blood Press Res; 2020; 45(2):275-285. PubMed ID: 32114578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Primary aldosteronism: The Mayo Clinic approach].
    Young W; Ladygina DO; Balutina OV; Beltsevich DG
    Ter Arkh; 2020 Nov; 92(10):83-87. PubMed ID: 33346484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
    Hundemer GL
    Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.